ENT Surgeryhttp://hdl.handle.net/20.500.12904/2002024-03-20T12:49:08Z2024-03-20T12:49:08ZComparison of side effects and patient perceptions towards rapid rhino and merocel packs in epistaxisConley, Peterhttp://hdl.handle.net/20.500.12904/182862024-03-06T12:23:39Z2024-01-17T00:00:00ZComparison of side effects and patient perceptions towards rapid rhino and merocel packs in epistaxis
Conley, Peter
Objective: Non-dissolvable nasal packs (Rapid Rhino and Merocel) are widely used in secondary healthcare centres for the control of epistaxis, with some side effects. Methods: A prospective, observational cohort study was conducted of adults who required Rapid Rhino or Merocel packing for acute epistaxis management in a large healthcare centre between March 2020 and 2021. A validated modified version of the 22-item Sino-Nasal Outcome Test was used. Results: A total of 80 adults requiring non-dissolvable packs were recruited. Seventy per cent of patients had Rapid Rhino packs inserted. Embarrassment was greater in patients who used Rapid Rhino than Merocel. Merocel packs had a significantly higher mean pain score on removal compared to Rapid Rhino. There was no correlation between rebleed rate and type of nasal pack used. Conclusion: Non-dissolvable Rapid Rhino and Merocel nasal packs have similar efficacy in controlling epistaxis. Rapid Rhino packs are more embarrassing for patients in comparison to Merocel packs, but are less painful to remove.
2024-01-17T00:00:00ZPredictive factors for subjective vertigo following cochlear implantation: a regional multicenter cohort study of 395 patientsMair, Manishhttp://hdl.handle.net/20.500.12904/179132023-11-24T11:19:04Z2023-10-19T00:00:00ZPredictive factors for subjective vertigo following cochlear implantation: a regional multicenter cohort study of 395 patients
Mair, Manish
Introduction: Cochlear implantation (CI) is generally accepted as having a low rate of postoperative complications, but between 9.3% and 13% of cases experience vertigo postoperatively. This study aimed to examine patient, surgical, and device factors contributing toward the risk of postoperative vertigo. Methodology: A retrospective review was conducted of adult patients who underwent cochlear implant in a regional area of New South Wales from 2007 to 2018. A total of 395 cochlear implant cases were included in the final study. Results: The overall incidence of vertigo at 3 months of follow-up was 7.1% (n = 28/395). No difference was identified in this study between rates of postoperative vertigo between device factors, including implant make (Cochlear vs. Med-El), electrode shape (perimodiolar vs. straight), and electrode model. No significant difference was found also for surgical factors such as the number of electrode rings inserted, side of implantation, or surgical approach of tympanic ramp (round window insertion vs. cochleostomy).A higher percentage of patients with preoperative vertigo experienced vertigo postoperatively (18.4%, n = 7/38), compared with the population without preoperative vertigo (6.0%, n = 21/352) (p = 0.005). Patients with previous mastoid surgery also reported a higher rate of postoperative vertigo (20%, n = 9/45) compared with those who had not had mastoid surgery (5.43%, n = 19/350) (p = 0.006). The mean age of patients experiencing postoperative vertigo was higher than the population without postoperative symptoms (67 vs. 63). Conclusion: This study of a large multicenter population outlines that patient factors are more critical than surgical or device factors when considering risk factors for vertigo post-cochlear implant.
2023-10-19T00:00:00ZRare cause of skull base osteomyelitis: a challenging diagnosis and management with a literature reviewHussain, Syed Zohaib MaroofEkonola, AyomideHaq, Ibrahim IDas, SudipArshad, Zakihttp://hdl.handle.net/20.500.12904/179102024-01-03T10:13:08Z2023-09-24T00:00:00ZRare cause of skull base osteomyelitis: a challenging diagnosis and management with a literature review
Hussain, Syed Zohaib Maroof; Ekonola, Ayomide; Haq, Ibrahim I; Das, Sudip; Arshad, Zaki
This is a case of skull base osteomyelitis (SBO) caused by a rare fungal species, Scedosporium apiospermum. This is a clinical case report with a review of the literature. SBO is a potentially life-threatening infection of the temporal bone. The patient presented to our hospital with a two-month history of left otalgia, otorrhea and reduced hearing, after failed initial intravenous antibiotic therapy. Thorough examination and further investigation confirmed the diagnosis of SBO caused by a rare fungal species, S. apiospermum. The patient was subsequently started on a long-term course of antifungals which led to an improvement of symptoms. This case highlights the importance of early recognition and considering early antifungal treatment in patients with persistent otalgia and otorrhea, particularly in those who have failed to respond to intravenous antibiotics. Further research is needed to better understand the optimal timing and duration of antifungal therapy in these patients.
2023-09-24T00:00:00ZBuilding a competitive application: exploring entry routes and educational choices of otolaryngology higher surgical trainees in the UKPatel, Sachin Tusharhttp://hdl.handle.net/20.500.12904/177162023-10-19T12:55:24Z2023-09-12T00:00:00ZBuilding a competitive application: exploring entry routes and educational choices of otolaryngology higher surgical trainees in the UK
Patel, Sachin Tushar
2023-09-12T00:00:00Z